Format

Send to

Choose Destination
See comment in PubMed Commons below
World J Surg. 2009 Aug;33(8):1750-6. doi: 10.1007/s00268-009-0079-2.

Oncologic outcome of intersphincteric resection for very low rectal cancer.

Author information

  • 1Colorectal and Pelvic Surgery Division, Department of Surgical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. norsaito@east.ncc.go.jp

Abstract

BACKGROUND:

In 2000 we launched a prospective program of intersphincteric resection (ISR) for very low rectal cancer. In this study we compared the oncologic outcome of patients who underwent ISR with the outcome of patients who underwent abdominoperineal resection (APR).

METHODS:

The data of 202 patients with very low rectal cancer who underwent curative ISR (n = 132) or curative APR (n = 70) between 1995 and 2006 were analyzed. Patients were divided into ISR and APR groups. Survival and local recurrence were investigated in both groups.

RESULTS:

The median follow-up was 40 months in the ISR group and 57 months in the APR group. The 5-year local relapse-free survival rate was 83% in the ISR group and 80% in the APR group (p = 0.364), and the 5-year disease-free survival rate was 69% in the ISR group and 63% in the APR group (p = 0.714).

CONCLUSIONS:

For very low rectal cancers, ISR appears to be oncologically acceptable and can reduce the number of APRs.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk